Anna Tankiewicz-Kwedlo (A Tankiewicz-Kwedlo)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 8

Top Venues

Cancers

Cells

British journal of pharmacology

Molecular and cellular biochemistry

Medical University of Białystok

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University of Białystok Oct 01 2012

Poland

Assistant Professor :: Department of Monitored Pharmacotherapy

Medical University of Białystok Feb 02 2007 - Oct 01 2012

Poland

Assistant Professor :: Department of Pharmacodynmics

Medical University of Białystok Oct 01 1999 - Feb 01 2007

Poland

Assistant :: Department of Pharmacodynamics

Publications

Marianna Ciwun, Anna Tankiewicz-Kwedlo, Dariusz Pawlak
Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy. Cancers 16 (6) (2024)
Adrian Mor, Anna Tankiewicz-Kwedlo, Marianna Ciwun, Janina Lewkowicz, Dariusz Pawlak
Kynurenines as a Novel Target for the Treatment of Inflammatory Disorders. Cells 13 (15) (2024)
Marianna Ciwun, Anna Tankiewicz-Kwedlo, Dariusz Pawlak
Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy. Cancers 16 (6) (2024)
Adrian Mor, Anna Tankiewicz-Kwedlo, Marianna Ciwun, Janina Lewkowicz, Dariusz Pawlak
Kynurenines as a Novel Target for the Treatment of Inflammatory Disorders. Cells 13 (15) (2024)
Anna Tankiewicz-Kwedlo, Tomasz Lobacz, Leszek Kozlowski, Bogumila Czartoryska-Arlukowicz, Mariusz Koda, Krystyna Pawlak, Robert Czarnomysy, Magdalena Joanna Borkowska, Dariusz Pawlak
ONCOBREAST-TEST Is a Quick Diagnostic, Prognostic and Predictive Method of Response to Systemic Treatment. Cancers 16 (1) (2023)
Anna Tankiewicz-Kwedlo, Tomasz Lobacz, Leszek Kozlowski, Bogumila Czartoryska-Arlukowicz, Mariusz Koda, Krystyna Pawlak, Robert Czarnomysy, Magdalena Joanna Borkowska, Dariusz Pawlak
ONCOBREAST-TEST Is a Quick Diagnostic, Prognostic and Predictive Method of Response to Systemic Treatment. Cancers 16 (1) (2023)
Anna Tankiewicz-Kwedlo, Justyna Magdalena Hermanowicz, Tomasz Domaniewski, Krystyna Pawlak, Małgorzata Rusak, Anna Pryczynicz, Arkadiusz Surazynski, Tomasz Kaminski, Adam Kazberuk, Dariusz Pawlak
Simultaneous use of erythropoietin and LFM-A13 as a new therapeutic approach for colorectal cancer. British journal of pharmacology 175 (5) (2018)
Anna Tankiewicz-Kwedlo, J Hermanowicz, A Surażynski, D Rożkiewicz, A Pryczynicz, T Domaniewski, K Pawlak, A Kemona, D Pawlak
Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts. Molecular and cellular biochemistry 421 (1-2) (2016)

Anna Tankiewicz-Kwedlo.css-eqlu8i{font-size:small;padding-left:4px;} (A Tankiewicz-Kwedlo)

Publication Activity (10 Years)

Top Topics

Top Venues

Anna Tankiewicz-Kwedlo (A Tankiewicz-Kwedlo)